glp 1 drugs metformin Do You Still Need If You Take a GLP-1 for Diabetes? Comparing Glucagon‐like peptide‐1 receptor agonists

This did not present a risk in the researchers sample because they excluded people with body-mass indices (BMIs) lower than 23 (the World Health Organization considers BMIs 18.5 24.9 normal), and most study participants had a BMI of 30 or more (classified as obese)

[20] Weight loss: Are there any natural alternatives to Ozempic

While we don't know the exact ApoB numbers from Triumph, if we look back at the Transcend 1 data showing that retatrutide was reducing ApoB at about a 1:1 rate as the LDL and we can presume a 20% drop in ApoB as well here

Mitochondrial and Cellular Benefits: Microdosing GLP-1 agonists may enhance how your cells make energy and protect against cellular aging

Tang ASP, Hsu JTY, Chong SKS et al (2025) Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety